Year archive

Ananda Pharma Plc — 2024 filings

All 39 regulatory filings released by Ananda Pharma Plc (ANAN) in 2024, sourced directly from the official regulator.

39 Filings

2024 Period

2024 filings (39)

Filing	Released	Lang
Change of Name Regulatory Filings	2024-12-20	English
Subscription to raise £150,000 Share Issue/Capital Change	2024-12-11	English
Further Promising Results for MRX1 Regulatory Filings	2024-12-09	English
Key Stability Testing Milestones Achieved for MRX1 Regulatory Filings	2024-12-03	English
Publication of article in Leading Journal Regulatory Filings	2024-11-25	English
Director Dealing Director's Dealing	2024-11-12	English
Presenting at Aquis Showcase Regulatory Filings	2024-11-04	English
Total Voting Rights Regulatory Filings	2024-10-31	English
Investor Meet Company Presentation Investor Presentation	2024-10-30	English
Interims for the six months ended 31 July 2024 Interim / Quarterly Report H1 2024	2024-10-30	English
Ananda Developments Epilepsy Trials Regulatory Filings	2024-10-21	English
Phase 1 PK Study to be conducted on MRX1 Regulatory Filings	2024-10-09	English
Result of General Meeting Declaration of Voting Results & Voting Rights Announcements	2024-10-08	English
Change of Location for General Meeting AGM Information	2024-10-08	English
Addition to Scientific Advisory Board Regulatory Filings	2024-10-07	English
Total Voting Rights Regulatory Filings	2024-09-30	English
Notice of General Meeting Regulatory Filings	2024-09-19	English
Result of WRAP Retail Offer Regulatory Filings	2024-09-16	English
WRAP Retail Offer for up to £100,000 Capital/Financing Update	2024-09-09	English
Placing and Subscription to raise c.£2.15 million Regulatory Filings	2024-09-09	English
Launch of CBD Whitepaper Report Publication Announcement	2024-08-29	English
Management accounts for quarter ended 31 July 2024 Interim / Quarterly Report Q2 2024	2024-08-29	English
Result of AGM Declaration of Voting Results & Voting Rights Announcements	2024-08-09	English
Graduation to Apex segment of AQSE Growth Market Regulatory Filings	2024-08-05	English
Notice of AGM AGM Information	2024-07-16	English
Publication of Annual Report and Accounts Audit Report / Information FY 2024	2024-07-15	English
Invitation to Investor Evening Regulatory Filings	2024-07-11	English
Promising Results from Cardiac Fibrosis Studies Regulatory Filings	2024-06-26	English
Extension of Mark Ling as Senior Statutory Auditor Audit Report / Information FY 2024	2024-06-11	English
Ananda joins cannabinoid R&D Group Regulatory Filings	2024-05-31	English
Quarterly Trading Statement to 30 April 2024 Interim / Quarterly Report Q1 2024	2024-05-30	English
Ananda Presentation to LSX Conference 2024 Regulatory Filings	2024-05-14	English
Response to FSA-FSS Cannabidiol Safety Assessment Regulatory Filings	2024-05-02	English
Establishment of Scientific Advisory Board Regulatory Filings	2024-03-21	English
Endometriosis Trial Drug Supply Agreement Signed Regulatory Filings	2024-02-28	English
Ananda presenting at Master Investor Show Regulatory Filings	2024-02-26	English
Quarterly Trading Statement to 31 January 2024 Interim / Quarterly Report Q4 2024	2024-02-26	English
Appointment of Adviser Regulatory Filings	2024-02-06	English
Appointment of Scientific Advisers Regulatory Filings	2024-01-23	English